Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FV5BE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,175
Award facts
- Contract value 100% obligated
- $5,174.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.80 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on October 28, 2025, with a completion date of November 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through firm fixed-price procurement without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery order supports the Department of Defense's pharmaceutical supply chain requirements for medical products distributed to military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. Awarded on November 13, 2025, this prime vendor contract carries a $499.999 billion ceiling value and extends through December 31, 2036, authorizing the DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables. As one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a critical supplier for Department of Defense healthcare operations globally, with demonstrated performance across diverse therapeutic categories including specialty pharmaceuticals, biologics, vaccines, and medical consumables.
Quick answers
Who was awarded contract SPE2DB26FV5BE?
SPE2DB26FV5BE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FV5BE worth?
The government has obligated $5,175 on SPE2DB26FV5BE.
Is contract SPE2DB26FV5BE an order under another contract?
Yes. SPE2DB26FV5BE is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB26FV5BE competed?
The extent of competition for SPE2DB26FV5BE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award